PD
VYGR icon

Point72 (DIFC)’s Voyager Therapeutics VYGR Stock Holding History

Point72 (DIFC)’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$794 Buy
+170
New +$615 ﹤0.01% 1061
2025
Q1 		– Sell
-10,618
Closed -$60.2K – 2105
2024
Q4 		$60.2K Buy
+10,618
New +$68.5K ﹤0.01% 1096

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 (DIFC)'s VYGR Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Voyager Therapeutics (VYGR) in Q3 2025: 170 shares worth $794. The stake represents ﹤0.01% of the portfolio and ranks #1061 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in VYGR as recently as Q4 2024.

Point72 (DIFC) first reported a position in VYGR in Q4 2024 and has held it in 2 quarters since. The position peaked at $60.2K in Q4 2024. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Point72 (DIFC) held 170 shares of Voyager Therapeutics worth $794 as of Q3 2025.
  • Voyager Therapeutics was a new Point72 (DIFC) position in Q3 2025.
  • Voyager Therapeutics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1061 holding.
  • Point72 (DIFC) first reported a position in Voyager Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • Point72 (DIFC)'s Voyager Therapeutics position peaked at $60.2K in Q4 2024.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.